Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz’s Carol Lynch talks about the “Big Break” for biosimilars
May 18, 2015
Read The Medicine Maker’s Biosimilars special edition, including an interview with Carol Lynch, Sandoz Head of Biopharmaceuticals & Oncology Injectables.
The Medicine Maker interviews Sandoz’s Nick Haggar
November 24, 2014
Nick Haggar: “Opening up access to medicine is something Sandoz takes seriously.”
“In Italy, patients receive biosimilars as first-line therapies”
November 11, 2014
Nick Haggar, Sandoz Head of Western Europe, Middle East & Africa and President of the European Generic Medicines Association (EGA), talks to leading Spanish newspaper "La Razón" about how to ensure the success of biosimilars in Spain, Europe and beyond.
Promoting the safety, efficacy and value of generic medicines
November 04, 2014
Nick Haggar, President of the European Generic medicines Association (EGA) and Sandoz Head of Western Europe, Middle East & Africa, talks to Romania’s Health Policy Journal about the growing importance of generic medicines and the EGA’s long-term vision for sustainable global access to affordable, high-quality healthcare.
Efficacy of generics depends on quality
October 14, 2014
Richard Francis, Global Head of Sandoz, talked to leading Russian newspaper Rossiyskaya Gazeta about how to ensure the quality and efficacy of generics.